• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446)
Event Date 02/11/2021
Event Type  Injury  
Manufacturer Narrative
Article citation: chaudhry- waterman n, shapiro s, thompson j.Use of the noblestitch¿ el for the treatment of patients with residual right- to- left shunt following device closure of pfo.Clin case rep.2021;9:1929¿ 1932.Https://doi.Org/10.1002/ccr3.3906.Additional information was requested from the author but was not provided.The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: repeat procedure to the septal defect, intervention for device failure or ineffectiveness and new arrhythmia requiring treatment,.
 
Event Description
This information was received through literature article "use of the noblestitch¿ el for the treatment of patients with residual right- to- left shunt following device closure of pfo" published clinical case rep.2021.The articles objective/aim is to report the successful use of the noblestitch¿ el to close residual defects in two patients who remained symptomatic after device partial pfo closure.The article reports case 2: a (b)(6) year-old man with klinefelter's syndrome and a history of pfo closure with a gore cardioform device due to platypnea-orthodeoxia syndrome presented to the adult cardiology clinic.In the year since his pfo closure, he had developed supraventricular tachycardia (svt) requiring ablation, atrial fibrillation requiring medical management with beta blockers and anticoagulation, and he had continued to experience shortness of breath and had documented desaturations with minimal exercise.Right heart catheterization at an outside hospital showed he had developed heart failure with preserved ejection fraction (hfpef).Tte showed continued atrial right- to- left shunting.At cardiac catheterization, initial ice showed the device's left disk capturing the primum septum.However, the right disk was within the pfo tunnel and did not capture the secundum septum.In addition, an atrial septal aneurysm was present.As assessed by the sizing balloon, the residual pfo tunnel was 5 mm in diameter and 11 mm in length.The secundum suture of the noblestitch¿ el was used to capture the secundum atrial septum.Next, the primum suture was used to capture the superior margin of the cardioform device, effectively serving as the primum septum.Following kwiknot deployment, angiography showed a blind-ending tunnel.By contrast ice, there was a trivial residual shunt.At six month follow-up, repeat ctte both at rest and with valsalva showed no residual shunting.The patient has now experienced complete resolution of symptoms.He continues on anticoagulation and beta- blockers for management of his underlying atrial fibrillation, but has not had any episodes of palpitations since prior to the procedure.Case 1 in the article is captured in case (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12318763
MDR Text Key266413158
Report Number2017233-2021-02258
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
-
-